The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2019 | Managing oligometastatic NSCLC with thoracic irradiation
Françoise Mornex, MD, PhD, of Claude Bernard University, Lyon, France, talks about the use of thoracic irradiation in patients with oligometastatic non-small cell lung cancer (NSCLC). Speaking at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland, Prof. Mornex reports that currently, there is little data to support the efficacy of this method and so more research is required to confirm the promises of using thoracic irradiation for oligometastatic NSCLC.
